Works matching IS 20555822 AND DT 2021 AND VI 8 AND IP 2
Results: 111
Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE‐FMR trial.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 872, doi. 10.1002/ehf2.13273
- By:
- Publication type:
- Article
Quantifying the relationship and contribution of mitochondrial respiration to systemic exercise limitation in heart failure.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 898, doi. 10.1002/ehf2.13272
- By:
- Publication type:
- Article
Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus‐positive patient with fulminant myocarditis.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1643, doi. 10.1002/ehf2.13271
- By:
- Publication type:
- Article
Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1596, doi. 10.1002/ehf2.13267
- By:
- Publication type:
- Article
Changes in cardiac sympathetic nerve activity on <sup>123</sup>I‐metaiodobenzylguanidine scintigraphy after MitraClip therapy.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1590, doi. 10.1002/ehf2.13266
- By:
- Publication type:
- Article
Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1582, doi. 10.1002/ehf2.13264
- By:
- Publication type:
- Article
Multiparameter diagnostic sensor measurements during clinically stable periods and worsening heart failure in ambulatory patients.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1571, doi. 10.1002/ehf2.13261
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2021
- Publication type:
- Correction Notice
Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT‐AHF trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1562, doi. 10.1002/ehf2.13257
- By:
- Publication type:
- Article
Sarcopenia in heart failure: a systematic review and meta‐analysis.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1007, doi. 10.1002/ehf2.13255
- By:
- Publication type:
- Article
The impact of frailty according to Clinical Frailty Scale on clinical outcome in patients with heart failure.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1552, doi. 10.1002/ehf2.13254
- By:
- Publication type:
- Article
Simple equations to predict the effects of veno‐venous ECMO in decompensated Eisenmenger syndrome.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1637, doi. 10.1002/ehf2.13253
- By:
- Publication type:
- Article
Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1541, doi. 10.1002/ehf2.13252
- By:
- Publication type:
- Article
Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 842, doi. 10.1002/ehf2.13250
- By:
- Publication type:
- Article
Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1717, doi. 10.1002/ehf2.13249
- By:
- Publication type:
- Article
Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1531, doi. 10.1002/ehf2.13247
- By:
- Publication type:
- Article
Aortic pulsatility index predicts clinical outcomes in heart failure: a sub‐analysis of the ESCAPE trial.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1522, doi. 10.1002/ehf2.13246
- By:
- Publication type:
- Article
Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1509, doi. 10.1002/ehf2.13245
- By:
- Publication type:
- Article
Pump thrombosis and dynamic outflow graft compression: complications in left ventricular assist device therapy.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1631, doi. 10.1002/ehf2.13244
- By:
- Publication type:
- Article
Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1502, doi. 10.1002/ehf2.13243
- By:
- Publication type:
- Article
Cardio‐microcurrent device for chronic heart failure: first‐in‐human clinical study.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 962, doi. 10.1002/ehf2.13242
- By:
- Publication type:
- Article
Meta‐analysis of the effects of four factors on the efficacy of SGLT2 inhibitors in patients with HFrEF.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
A New Requirement for Publication: Access to Effective Drugs for Ethical Reasons, The Example of Heart Failure.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 799, doi. 10.1002/ehf2.13240
- By:
- Publication type:
- Article
Prognostic impact of elevated fatty acid‐binding protein 1 in patients with heart failure.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1494, doi. 10.1002/ehf2.13239
- By:
- Publication type:
- Article
Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 861, doi. 10.1002/ehf2.13237
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1482, doi. 10.1002/ehf2.13236
- By:
- Publication type:
- Article
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1711, doi. 10.1002/ehf2.13235
- By:
- Publication type:
- Article
Predicting outcome in children with dilated cardiomyopathy: the use of repeated measurements of risk factors for outcome.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1472, doi. 10.1002/ehf2.13233
- By:
- Publication type:
- Article
The course of patients with Chagas heart disease during episodes of decompensated heart failure.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1460, doi. 10.1002/ehf2.13232
- By:
- Publication type:
- Article
INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 849, doi. 10.1002/ehf2.13231
- By:
- Publication type:
- Article
Prevalence of low health literacy levels in decompensated heart failure compared with acute myocardial infarction patients.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1446, doi. 10.1002/ehf2.13230
- By:
- Publication type:
- Article
Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1438, doi. 10.1002/ehf2.13229
- By:
- Publication type:
- Article
Endothelial NADPH oxidase 4 protects against angiotensin II‐induced cardiac fibrosis and inflammation.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1427, doi. 10.1002/ehf2.13228
- By:
- Publication type:
- Article
The effect of three major co‐morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1417, doi. 10.1002/ehf2.13227
- By:
- Publication type:
- Article
Fluid overload in patients undergoing TAVR: what we can learn from the nephrologists.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1408, doi. 10.1002/ehf2.13226
- By:
- Publication type:
- Article
Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1706, doi. 10.1002/ehf2.13225
- By:
- Publication type:
- Article
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1398, doi. 10.1002/ehf2.13224
- By:
- Publication type:
- Article
Non‐alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 789, doi. 10.1002/ehf2.13222
- By:
- Publication type:
- Article
Hospital readmissions of patients with heart failure from real world: timing and associated risk factors.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1388, doi. 10.1002/ehf2.13221
- By:
- Publication type:
- Article
Low‐fat hypocaloric diet reduces neprilysin in overweight and obese human subjects.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 938, doi. 10.1002/ehf2.13220
- By:
- Publication type:
- Article
Predicting the clinical course in hypertrophic cardiomyopathy using thallium‐201 myocardial scintigraphy.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1378, doi. 10.1002/ehf2.13218
- By:
- Publication type:
- Article
Usefulness of CHADS2, R2CHADS2, and CHA2DS2‐VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1369, doi. 10.1002/ehf2.13217
- By:
- Publication type:
- Article
A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1359, doi. 10.1002/ehf2.13216
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2021
- Publication type:
- Correction Notice
Development and implementation of a remote patient monitoring program for heart failure: a single‐centre experience.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1349, doi. 10.1002/ehf2.13214
- By:
- Publication type:
- Article
High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1342, doi. 10.1002/ehf2.13213
- By:
- Publication type:
- Article
Reply to: More data about cardiac and neurologic findings would be useful.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Clinical profile and midterm prognosis of left ventricular thrombus in heart failure.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1333, doi. 10.1002/ehf2.13211
- By:
- Publication type:
- Article
Myotonic dystrophy patients: More data about cardiac and neurologic findings would be useful.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor